Beckman Coulter Life Sciences, Miami, Fla, has launched the Kaluza Cflow cytometry analysis software, an advanced data analysis system for the clinical laboratory. The new software streamlines clinical quality control reporting and addresses standardization issues in flow cytometry.

Kaluza C is CE marked and listed with FDA. It builds on the company’s existing Kaluza analysis software, which is already an essential analysis tool for life science researchers.

Kaluza C software improves the visualization and analysis of rare events. The system enables users to process large, multicolor files with up to 20 million events, and set the plot resolution according to the gate level. Further, to preserve the integrity of the scatter plot, it enables the operator to focus on a limited number of events. To improve the analysis of complex datasets, tools such as easy Boolean gate formation and autogating are also incorporated. It takes less than a second to adjust the compensation and calculate compensation values.


Mario Koksch, PhD, Beckman Coulter Life Sciences.

“Kaluza C offers laboratories the opportunity to improve their clinical reporting,” says Mario Koksch, MD, PhD, vice president and general manager of the cytometry business unit at Beckman Coulter. “It provides support at several levels, from quality control and regulatory compliance to ease of use and advanced user management tools. Complex clinical reporting can now be done in minutes, helping to improve workflow, reduce turnaround time, and enhance the diagnostic pathway.”

Kaluza C incorporates quality control visualization tools for regulatory and quality control compliance. The software also offers a range of user management tools—from report page generation to auditing work levels and traceability—and enables easy exporting of data into the main laboratory information system. It can analyze clinical data from any cytometer that complies with the official flow cytometry standard (FCS).

“Meeting regulatory requirements for complex flow cytometry testing is demanding on both time and expertise,” Koksch says. “Kaluza C empowers clinical flow cytometrists, giving them the confidence to approach their work in a different way and so achieve greater efficiencies.”

For more information visit Beckman Coulter.